Kuros Biosciences AG (SWX:KURN)

Kuros Biosciences AG Revenue

Kuros Biosciences AG had revenue of $92.35M USD in the half year ending June 30, 2026, with 158.81% growth. This brings the company's revenue in the last twelve months to $174.93M, up 54.87% year-over-year. In the year 2025, Kuros Biosciences AG had annual revenue of $146.06M with 71.51% growth.

• Revenue (ttm): $174.93M
• Revenue Growth: +54.87%
• P/S Ratio: 6.04
• Revenue / Employee: $982.76K
• Employees: 178
• Market Cap: 853.74M CHF

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	146.06M	60.90M	71.51%
Dec 31, 2024	85.16M	45.25M	113.38%
Dec 31, 2023	39.91M	20.46M	105.15%
Dec 31, 2022	19.45M	4.30M	28.39%
Dec 31, 2021	15.15M	10.66M	237.01%
Dec 31, 2020	4.50M	1.85M	69.84%
Dec 31, 2019	2.65M	1.92M	264.23%
Dec 31, 2018	726.81K	178.92K	32.66%
Dec 31, 2017	547.90K	-494.55K	-47.44%
Dec 31, 2016	1.04M	898.38K	623.61%
Dec 31, 2015	144.06K	-862.63K	-85.69%
Dec 31, 2014	1.01M	-114.00K	-10.17%
Dec 31, 2013	1.12M	-81.17K	-6.75%
Dec 31, 2012	1.20M	-470.53K	-28.14%
Dec 31, 2011	1.67M	-22.24M	-93.01%
Dec 31, 2010	23.91M	20.60M	622.19%
Dec 31, 2005	3.31M	-	-

Data Source: Fiscal.ai Last updated: Aug 12, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 19, 2026

Data Sources Report a data error